Servier

The key figures 2006

First independent French pharmaceutical group

Second French pharmaceutical group on a world level

SERVIER is present in 140 countries

82% of the consumption of the Servier drugs is made with the international one.

Turnover consolidated for 2005/2006: 3,3 billion euros

Close to 25% of the Servier turnover is devoted to the Research and the Development

20.000 collaborators in the world including 2600 in the Development and research sector

The Servier drugs

670 million boxes of drugs was availability of the patients in 2006 by the production sites.

The Clinical Unit of Support Servier with Gidy (close to Orleans) is the greatest production unit of drugs for Clinical trials of Europe

The Servier Research and development

The heart of the innovation and progress

“a Group which succeeds in its Research is likely all to succeed everywhere in the world. Research it is our mission, it is the essential work of the industry of the drug, it is in this work that it is necessary to succeed”. Dr. Jacques Servier

Exceptional means

Nearly 25% of the turnover Servier is devoted to the R & D

Servier spends each year nearly 25% of his turnover.

30 drugs were recorded in 30 years.

All drugs SERVIER result from its research laboratories and Développement.

Servier is one of the very first private partners of INSERM; he is also a privileged partner of CNRS.

Research orientations of Servier

Neurosciences
Cancerology
Cardiovascular Pathologies
Metabolic Diseases
Rhumatologie
Search for upstream

History

The laboratory was created initially in 1954 by Jacques Servier with Orleans with nine there working people. The research unit is always installed there.

Random links: